PJWM
BIIB icon

Philip James Wealth Mangement’s Biogen BIIB Stock Holding History

Philip James Wealth Mangement’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Sell
1,702
-621
-27% -$119K 0.04% 118
2026
Q1 		$426K Sell
2,323
-5
-0.2% -$921 0.05% 122
2025
Q4 		$410K Buy
2,328
+182
+8% +$29.7K 0.05% 128
2025
Q3 		$301K Buy
+2,146
New +$290K 0.04% 152

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Philip James Wealth Mangement's BIIB Position: Q2 2026 in Review

Philip James Wealth Mangement reduced its Biogen (BIIB) stake by 27% in Q2 2026, selling an estimated $119K and leaving 1,702 shares worth $368K. The position accounts for 0.04% of the portfolio, ranked #118.

Philip James Wealth Mangement first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. The position peaked at $426K in Q1 2026. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Philip James Wealth Mangement held 1,702 shares of Biogen worth $368K as of Q2 2026.
  • Philip James Wealth Mangement sold 621 Biogen shares in Q2 2026, an estimated $119K.
  • Biogen made up 0.04% of Philip James Wealth Mangement's portfolio in Q2 2026, its #118 holding.
  • Philip James Wealth Mangement first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
  • Philip James Wealth Mangement's Biogen position peaked at $426K in Q1 2026.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Philip James Wealth Mangement's 13F filing for Q2 2026, filed 27 Jul 2026.